Nicola Fusco, M.D.
Nicola Fusco, M.D.
European Institute of Oncology (IEO), University of Milan, Italy
Verified email at unimi.it
Title
Cited by
Cited by
Year
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166-1169, 2014
1672014
The genomic landscape of male breast cancers
S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ...
Clinical Cancer Research 22 (16), 4045-4056, 2016
1212016
MED12 somatic mutations in fibroadenomas and phyllodes tumors of the breast
S Piscuoglio, M Murray, N Fusco, C Marchiò, FL Loo, LG Martelotto, ...
Histopathology 67 (5), 719, 2015
772015
Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer
G Valente, F Morani, G Nicotra, N Fusco, C Peracchio, R Titone, O Alabiso, ...
BioMed research international 2014, 2014
692014
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer
N Fusco, FC Geyer, MR De Filippo, LG Martelotto, CKY Ng, S Piscuoglio, ...
Modern Pathology 29 (11), 1292-1305, 2016
632016
HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions
N Fusco, EG Rocco, C Del Conte, C Pellegrini, G Bulfamante, F Di Nuovo, ...
Modern Pathology 26 (6), 816-824, 2013
562013
Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations
E Guerini‐Rocco, S Piscuoglio, CKY Ng, FC Geyer, MR De Filippo, ...
The Journal of pathology 238 (5), 677-688, 2016
452016
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study
E Guerini‐Rocco, Z Hodi, S Piscuoglio, CKY Ng, EA Rakha, ...
The Journal of pathology 237 (2), 166-178, 2015
452015
Mismatch repair protein loss as a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability
N Fusco, G Lopez, C Corti, C Pesenti, P Colapietro, G Ercoli, G Gaudioso, ...
JNCI Cancer Spectrum 2 (4), pky056, 2018
402018
Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management
A Michelotti, M Invernizzi, G Lopez, D Lorenzini, F Nesa, A De Sire, ...
The Breast 44, 15-23, 2019
392019
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYBNFIB fusion gene
J Kim, FC Geyer, LG Martelotto, CKY Ng, RS Lim, P Selenica, A Li, ...
The Journal of pathology 244 (2), 143-150, 2018
392018
Targeting immune-related biological processes in solid tumors: we do need biomarkers
F Pagni, E Guerini-Rocco, AM Schultheis, G Grazia, E Rijavec, M Ghidini, ...
International journal of molecular sciences 20 (21), 5452, 2019
342019
HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
N Fusco, S Bosari
World journal of gastroenterology 22 (35), 7926, 2016
332016
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study
A de Sire, A Baricich, F Renò, C Cisari, N Fusco, M Invernizzi
Aging clinical and experimental research 32 (5), 959-962, 2020
282020
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases
L De Mattos-Arruda, CKY Ng, S Piscuoglio, M Gonzalez-Cao, RS Lim, ...
Oncotarget 9 (29), 20617, 2018
262018
Therapeutic potential of immunoproteasome inhibition in Duchenne muscular dystrophy
A Farini, C Sitzia, B Cassani, L Cassinelli, R Rigoni, F Colleoni, N Fusco, ...
Molecular Therapy 24 (11), 1898-1912, 2016
242016
Breast cancer systemic treatments and upper limb lymphedema: a risk-assessment platform encompassing tumor-specific pathological features reveals the potential role of trastuzumab
M Invernizzi, A Michelotti, M Noale, G Lopez, L Runza, M Giroda, ...
Journal of clinical medicine 8 (2), 138, 2019
232019
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging
A Smith, M Galli, I Piga, V Denti, M Stella, C Chinello, N Fusco, D Leni, ...
Journal of proteomics 191, 114-123, 2019
222019
Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild‐type classic polymorphous low‐grade adenocarcinomas of the salivary gland
S Piscuoglio, N Fusco, CKY Ng, LG Martelotto, A da Cruz Paula, N Katabi, ...
Histopathology 68 (7), 1055-1062, 2016
212016
PTEN alterations and their role in cancer management: are we making headway on precision medicine?
N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, ...
Genes 11 (7), 719, 2020
202020
The system can't perform the operation now. Try again later.
Articles 1–20